Park J, Kim SI, Jeong SY, Kim Y, et al. Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study. Gynecol Oncol 2022 Feb 10. pii: S0090-8258(22)00086.
PMID: 35153073